Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: Longitudinal analyses from the randomized phase III ExteNET trial

  1. Delaloge, S.
  2. Cella, D.
  3. Ye, Y.
  4. Buyse, M.
  5. Chan, A.
  6. Barrios, C.H.
  7. Holmes, F.A.
  8. Mansi, J.
  9. Iwata, H.
  10. Ejlertsen, B.
  11. Moy, B.
  12. Chia, S.K.L.
  13. Gnant, M.
  14. Smichkoska, S.
  15. Ciceniene, A.
  16. Martinez, N.
  17. Filipović, S.
  18. Ben-Baruch, N.E.
  19. Joy, A.A.
  20. Langkjer, S.T.
  21. Senecal, F.
  22. De Boer, R.H.
  23. Moran, S.
  24. Yao, B.
  25. Bryce, R.
  26. Auerbach, A.
  27. Fallowfield, L.
  28. Martin, M.
  29. Show all authors +
Journal:
Annals of Oncology

ISSN: 1569-8041 0923-7534

Year of publication: 2019

Volume: 30

Issue: 4

Pages: 567-574

Type: Article

DOI: 10.1093/ANNONC/MDZ016 GOOGLE SCHOLAR lock_openOpen access editor